Mission Therapeutics is a company specializing in deubiquitylating enzyme drug discovery and development. It offers a platform for the discovery and development of small-molecule drugs that selectively target deubiquitylating enzymes (DUBs). The platform combines disease biology, screening tools, and chemistry, thereby generating a pipeline of highly potent and specific small-molecule drug candidates that have clinical and commercial potential.
|HQ||Great Abington, GB||Map|
|Employees (est.) (Sept 2021)||39||(+3%)|
Mission Therapeutics total Funding
Mission Therapeutics latest funding size
Time since last funding
|a year ago|
Mission Therapeutics investors
|SR One, Sofinnova Partners, Roche Venture Fund, Imperial Innovations, Pfizer Venture Investments, Woodford Investment Management, Pfizer Ventures, IP Group and Schroders Adveq|
Mission Therapeutics has 1.43k Twitter Followers. The number of followers has increased 0.5% month over month and increased 2% quarter over quarter
When was Mission Therapeutics founded?
Mission Therapeutics was founded in 2011.
Who are Mission Therapeutics key executives?
Mission Therapeutics's key executives are Colin Goddard, Anker Lundemose and Steve Jackson.
How many employees does Mission Therapeutics have?
Mission Therapeutics has 39 employees.
Who are Mission Therapeutics competitors?
Competitors of Mission Therapeutics include Hisamitsu Pharmaceutical, Egis Pharmaceuticals and Maruishi Pharmaceutical.
Where is Mission Therapeutics headquarters?
Mission Therapeutics headquarters is located at Granta Park, Great Abington.
Where are Mission Therapeutics offices?
Mission Therapeutics has offices in Great Abington and Cambridge.
How many offices does Mission Therapeutics have?
Mission Therapeutics has 2 offices.
Receive alerts for 300+ data fields across thousands of companies